Test Catalog Search Results
Suggested for -nE:
Test FNFAS is obsolete. Please see the notice for more details.
6MAMX - Overview: 6-Monoacetylmorphine, Chain of Custody, Random, Urine
Determination of heroin use Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen by demonstrating that, it is always...
DD22F - Overview: 22q11.2 Deletion/Duplication, FISH, Varies
Establishing a diagnosis of 22q deletion/duplication syndromes Detecting cryptic rearrangements involving 22q11.2 or 22q11.3 that are not demonstrated by conventional chromosome studies
HIAAP - Overview: 5-Hydroxyindoleacetic Acid, Plasma
Biochemical diagnosis and monitoring of intestinal carcinoid syndrome using a plasma specimen
21DOC - Overview: 21-Deoxycortisol, Serum
As an adjunct to measurement of 17-hydroxyprogesterone, androstenedione, and cortisol in the diagnosis of difficult cases of suspected 21-hydroxylase (CYP21A2) deficiency Identifying heterozygote CYP21A2 deficiency carriers As an adjunct...
F68KD - Overview: 68kD (hsp-70) antibodies by Line Blot
68kD (hsp-70) antibodies by Line Blot
6MAMM - Overview: 6-Monoacetylmorphine (6-MAM), Confirmation, Meconium
Detection of in utero heroin exposure up to 5 months before birth
MAMMX - Overview: 6-Monoacetylmorphine (6-MAM) Confirmation, Chain of Custody, Meconium
Detecting in utero heroin exposure up to 5 months before birth Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen...
OHPG - Overview: 17-Hydroxyprogesterone, Serum
Screening test for congenital adrenal hyperplasia (CAH), caused by either 11- or 21-hydroxylase deficiency, when used in combination with testing for cortisol and androstenedione As part of a battery of tests to evaluate women with...
F5M - Overview: 5-Methyltetrahydrofolate
5-Methyltetrahydrofolate
FLUC - Overview: 5-Flucytosine, Serum
Monitoring serum concentration during therapy Evaluating potential toxicity May aid in evaluating patient compliance
6MAMU - Overview: 6-Monoacetylmorphine Confirmation, Random, Urine
Determination of heroin use
FHC18 - Overview: 18-Hydroxycorticosterone, Serum
18-Hydroxycorticosterone, Serum
F11DX - Overview: 11-Desoxycortisol
11-Desoxycortisol
FAPCP - Overview: Fatty Acid Profile, Comprehensive (C8-C26), Serum
Monitoring patients undergoing diet therapy for mitochondrial or peroxisomal disorders (possibly inducing essential fatty acid deficiency in response to restricted fat intake) using serum specimens Monitoring treatment of essential fatty...
PFAPC - Overview: Fatty Acid Profile, Comprehensive (C8-C26), Plasma
Monitoring patients undergoing diet therapy for mitochondrial or peroxisomal disorders (possibly inducing essential fatty acid deficiency in response to restricted fat intake) using plasma specimens Monitoring treatment of essential fatty...
CHRBM - Overview: Chromosome Analysis, Hematologic Disorders, Bone Marrow
Assisting in the diagnosis and classification of certain malignant hematological disorders in bone marrow specimens Evaluating the prognosis in patients with certain malignant hematologic disorders Monitoring effects of treatment...
PD2T - Overview: Pompe Disease Second-Tier Newborn Screening, Blood Spot
Second-tier testing of newborns with an abnormal primary screening result for Pompe disease (decreased acid alpha-glucosidase enzyme activity) Follow-up testing for evaluation of an abnormal newborn screening result for Pompe disease
CHRHB - Overview: Chromosome Analysis, Hematologic Disorders, Blood
Assisting in the classification and follow-up of certain malignant hematological disorders when bone marrow is not available This test is not useful for congenital disorders.
PDBS - Overview: Pompe Disease, Blood Spot
Evaluating patients with a clinical presentation suggestive of Pompe disease (muscle hypotonia, weakness, or cardiomyopathy) outside of the newborn screening setting
ALPGP - Overview: Alport Syndrome Gene Panel, Varies
Providing a genetic evaluation for patients with a personal or family history suggestive of Alport syndrome Establishing a diagnosis of Alport syndrome
POLET - Overview: POLE Mutation Analysis, Next-Generation Sequencing, Tumor
Identifying specific mutations within the POLE gene to assist in tumor diagnosis/classification
GPSY - Overview: Glucopsychosine, Blood Spot
Second-tier test when newborn screening results with reduced beta-glucosidase (GBA) activity are identified Diagnosis and monitoring of patients with Gaucher disease using dried blood spot specimens Monitoring a patient's response to...
LPCBS - Overview: Lysophosphatidylcholines, LC MS/MS, Blood Spot
Second-tier newborn screen for X-linked adrenoleukodystrophy This test is not intended for metabolic screening of symptomatic patients. This test is supplemental and not intended to replace state mandated newborn screening.
GPNMB - Overview: Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB), Technical Component Only
Screening kidney tumors for genetic alterations
LD - Overview: Lactate Dehydrogenase (LDH), Serum
Investigation of a variety of diseases involving the heart, liver, muscle, kidney, lung, and blood Monitoring changes in tumor burden after chemotherapy; lactate dehydrogenase elevations in patients with cancer are too erratic to be of...
Second-tier testing of newborns with an abnormal primary screening result for mucopolysaccharidosis type I (MPS I, decreased alpha-L-iduronidase activity) where quantitation of the glycosaminoglycans dermatan and heparan sulfate is desired...
GPSYW - Overview: Glucopsychosine, Blood
Second-tier test when newborn screening results with reduced beta-glucosidase (GBA) activity are identified Diagnosis and monitoring of patients with Gaucher disease using whole blood specimens Supporting the biochemical diagnosis of...
Second-tier testing of newborns with an abnormal primary screening result for mucopolysaccharidosis type I (MPS I) (decreased alpha-L-iduronidase activity) Follow-up testing for evaluation of an abnormal newborn screening result for MPS...
COWB - Overview: Cobalt, Blood
Monitoring exposure to cobalt using whole blood specimens Monitoring metallic prosthetic implant wear This test is not useful for assessment of vitamin B12 activity.
TIWB - Overview: Titanium, Blood
Detecting and monitoring titanium exposure and potential implant status in patients with orthopedic implants
SEWB - Overview: Selenium, Blood
Assessment of tissue stores of selenium
FFTEN - Overview: Tetrahydrobiopterin and Neopterin Profile (BH4, N)
Tetrahydrobiopterin and Neopterin Profile (BH4, N)
FC4AL - Overview: C4 Level by RIA
C4 Level by RIA
LDALD - Overview: Lysosomal and Peroxisomal Disorders Newborn Screen, Blood Spot
First-tier newborn screen for the lysosomal disorders: Fabry, Gaucher, Krabbe, mucopolysaccharidosis I (MPS I) and II (MPS II), infantile neurovisceral or chronic visceral acid sphingomyelinase deficiency, and Pompe (glycogen storage...
PLSD - Overview: Lysosomal and Peroxisomal Disorders Screen, Blood Spot
Evaluation of patients with a clinical presentation suggestive of a lysosomal disorder, specifically Gaucher, infantile neurovisceral or chronic visceral acid sphingomyelinase deficiency, Pompe, Krabbe, or Fabry disease, or...
ZMMLS - Overview: Antimicrobial Susceptibility, Aerobic Bacteria, Varies
Determining the in vitro susceptibility of aerobic bacteria involved in human infections
C9FX - Overview: C9 Complement, Functional, Serum
Diagnosis of C9 deficiency Investigation of a patient with a low total (hemolytic) complement level
C7FX - Overview: C7 Complement, Functional, Serum
Diagnosis of C7 deficiency Investigation of a patient with an undetectable total complement level
C6FX - Overview: C6 Complement, Functional, Serum
Diagnosis of C6 deficiency Investigation of a patient with an undetectable total complement level
C5FX - Overview: C5 Complement, Functional, Serum
Diagnosis of C5 deficiency Investigation of a patient with an undetectable total complement level
C1QFX - Overview: C1q Complement, Functional, Serum
Diagnosis of C1 deficiency Investigation of a patient with an absent total complement level
C2 - Overview: C2 Complement, Functional, with Reflex, Serum
Investigation of a patient with a low (absent) hemolytic complement, with reflex testing to C3 and C4, if appropriate
C4FX - Overview: C4 Complement, Functional, Serum
Diagnosis of C4 deficiency Investigation of a patient with an undetectable total complement level
C8FX - Overview: C8 Complement, Functional, Serum
Diagnosis of C8 deficiency Investigation of a patient with an undetectable total hemolytic complement level
C2FXN - Overview: C2 Complement, Functional, Serum
Investigation of a patient with a low (absent) hemolytic complement
HBME - Overview: Mesothelial Cell (HBME-1) Immunostain, Technical Component Only
Classification of thyroid carcinomas
FADBC - Overview: Adenosine Deaminase, RBC
As a marker of severe combined immunodeficiency (SCID)
AUTOG - Overview: Autoinflammatory Disorders Gene Panel, Varies
Providing a comprehensive genetic evaluation for patients with a personal or family history suggestive of an inherited autoinflammatory disorder Establishing a diagnosis of a monogenic autoinflammatory disorder, allowing for appropriate...
BCELL - Overview: B-Cell and Antibody Deficiency Gene Panel, Varies
Providing a comprehensive genetic evaluation for patients with a personal or family history suggestive of an inherited primary B-cell disorder or humoral immunodeficiency Establishing a diagnosis of a primary B-cell disorder or humoral...
BTD - Overview: Biotinidase Deficiency, BTD Gene Sequencing with Deletion/Duplication, Varies
For confirming biotinidase deficiency as indicated by enzymatic testing or newborn screening Carrier testing of individuals with a family history of biotinidase deficiency, but disease-causing variants have not been identified in an...